U
UPB
UpStream Bio Inc.
17.92
0.12+0.67%After Hours: 17.92 0.00 0.00%16:32 09/11 EDT
OPEN/PREV CLOSE17.75/17.92
TODAY RANGE17.47-18.18
VOL305.37K
MARKET CAP966.06M
52 WEEK RANGE5.14-29.46
AVG VOL (3M)512.97K
% TURNOVER0.57%
TURNOVER--
P/E (TTM)-8.5906
% RANGE3.99%
EPS(TTM)-2.0860
P/E(FORWARD)-4.4245
P/B2.359
BVPS7.60
DIVIDEND--
P/S405.43
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP720.97M
SHARES OUTSTANDING53.91M
NEXT EARNINGS11/05-11/10
FREE FLOAT40.23M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·2d ago
Implied IWV Analyst Target Price: $410
TipRanks·09/04 11:25
TD Cowen Remains a Buy on Upstream Bio, Inc. (UPB)
TipRanks·09/03 11:16
Positive Phase 2 Results for Upstream Bio’s Verekitug Boost Stock Potential
Benzinga·09/02 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Dow Jones·09/02 17:56
Upstream Bio Shares Rise on Positive Data for Sinus-Disease Treatment
Benzinga·09/02 16:33
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds
TipRanks·09/02 13:00
Upstream Bio Announces Positive Phase 2 Trial Results
Benzinga·09/02 12:00
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
TipRanks·09/02 10:05
Upstream Bio’s verekitug meets endpoints in Phase 2 rhinosinusitis trial
Same Industry
Name/Symbol
Change%
Price